FlashPath AI

Integrated Safety Evidence for Drug Development

Connecting preclinical, clinical, and post-market safety data. Built for translational assessment.

Safety Intelligence Across the Drug Development Lifecycle

ToxiDex FlashAE
  1. Discovery
  2. Preclinical Safety
  3. Regulatory Review
  4. Clinical Trials
  5. Post-Market Safety

Most platforms sit at one stage. FlashPath spans them all.

Unified Safety Evidence

Connect toxicology studies, regulatory documents, clinical trials, and post-market safety data in one platform.

Translational Context

Understand how preclinical findings relate to downstream clinical outcomes and known safety risks.

Faster Investigation

Reduce the time required to contextualize findings across studies, compounds, and safety sources.

Built on a Large-Scale Safety Data Foundation

167,000+
compounds
24,000+
preclinical studies
39,000+
clinical trials
18 million+
post-market safety reports

Regulatory data from FDA, EMA, PMDA, Health Canada, and TGA.

Bridging Preclinical & Clinical Safety

See how FlashPath connects animal toxicology findings with real-world adverse event signals for the same compound.

Preclinical Findings ToxiDex
Clinical Adverse Events FlashAE

Why Customers Use FlashPath

Translational Safety Assessment

Contextualize preclinical findings using evidence from regulatory reviews, clinical trials, and post-market experience.

Signal Investigation

Explore whether related compounds, targets, or drug classes show similar safety findings.

Predictive Toxicology

Build and evaluate safety models using harmonized toxicology and clinical datasets.

Regulatory Intelligence

Review safety findings across global regulatory agencies and historical development programs.

Learn More